BioMarin's Chief Executive Jean-Jacques Bienaime to Receive Most Admired CEO Award From San Francisco Busi...( NOVATO Calif. Oct. 9 /- BioMarin Phar...)

NOVATO, Calif., Oct. 9 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that its Chief Executive Officer Jean-Jacques Bienaime will receive the Most Admired CEO Award from the San Francisco Business Times at a gala event to be held on November 19, 2009 in San Francisco. Mr. Bienaime is recognized for his outstanding leadership in the category of public companies with annual revenues of less than $500 million. Mr. Bienaime was selected by an independent panel of judges who considered multiple nominations for CEOs who consistently demonstrate excellent leadership of their companies, people, industries and communities. An advisory panel considered qualities including leadership, values, vision, company's financial performance, commitment to quality and diversity, work environment, community contributions, innovation and overcoming adversity.

"It is no coincidence that BioMarin has been named one of the San Francisco Bay Area's 'Best Places to Work'* for three consecutive years," said Mark Wood, BioMarin Vice President of Human Resources. "Mr. Bienaime has been the driving force behind the company's growth and success in recent years. Under his leadership, BioMarin has emerged as a leading fully integrated biopharmaceutical company, with an employee population that has doubled since his arrival, with employees in 20 countries worldwide."

During his five-year tenure at the company, Mr. Bienaime and his team have built BioMarin's market capitalization to highs of more than $3.5 billion, and revenues from $18.6 million to more than $300 million. The company has brought three biopharmaceutical products to market in just three to five years each, which is a remarkable accomplishment in the pharmaceutical industry where drug candidates typically require 10-12 years to progress from research to comme
'/>"/>